Evaluating XPERIENCE™ Advanced Surgical Irrigation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOttawa Hospital Research Institute
About this trial
A prospective, multi-center, double-arm, parallel, interventional, randomized, controlled clinical trial to assess the rate of periprosthetic joint infection (PJI) in patients undergoing primary total knee arthroplasty (TKA), total hip arthroplasty (THA) or hip resurfacing (HR) with XPERIENCE™ (XP) Advanced Surgical Irrigation versus dilute Betadine (DB).
Eligibility criteria
Qualifiers
Male and female patients aged 18 years or older
Diagnosis of osteoarthritis, inflammatory arthritis, osteonecrosis, or post-traumatic arthritis to the affected joint.
Primary TKA, THA, and HR
Subjects receiving both cemented or uncemented orthopaedic implants
Disqualifiers
Inability or refusal to sign informed consent form
Non-English or French speaking, and no licensed translator, family member or substitute decision maker available.
Prior arthroplasty procedure to the affected joint
Procedures involving solid HA implants
Trial design
Treatments tested in this trial
- XPERIENCE Advanced Surgical Irrigation
- Dilute Betadine
Treatment groups
7,600 Participants
are divided into 2 treatment groupsSponsors and collaborators
Ottawa Hospital Research Institute
Lead sponsor
OsteoRemedies, LLC
Collaborator
Source ClinicalTrials.gov